Alcon AG
Change company Symbol lookup
Select an option...
ALC Alcon AG
BEN Franklin Resources Inc
REGN Regeneron Pharmaceuticals Inc
PSNL Personalis Inc
CORR CorEnergy Infrastructure Trust Inc
SBRA Sabra Health Care REIT Inc
ZI ZoomInfo Technologies Inc
ATNI ATN International Inc
BAC Bank of America Corp
RACE Ferrari NV

Health Care : Health Care Equipment & Supplies | Large Cap Growth
Based in Switzerland
Company profile

Alcon AG is a Switzerland-based company specialized in the medical industry. The Company operates mainly as an eye care device company. Alcon AG reports its activities into two segments: Surgical and Vision Care. The surgical segment provides a line of ophthalmic surgical products that enable surgeons to achieve accurate results. Its surgical portfolio includes technologies and devices for cataract, retinal, refractive surgery, as well as advanced technology intraocular lenses (ATIOLs) to treat cataracts and refractive errors, such as presbyopia and astigmatism. The surgical segment also includes advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery. The Vision Care segment manufactures contact lenses and lens care products, such as products for dry eye, contact lens care, ocular allergies, as well as ocular vitamins and redness relievers. The Company also offers continuing education for eye care professionals.

Day's Change
0.64 (0.82%)
B/A Size
Day's High
Day's Low

Today's volume of 638,896 shares is on pace to be in-line with ALC's 10-day average volume of 862,145 shares.


Dow, S&P 500 sweep to record closes in 2022's first session, while Nasdaq has biggest gain in a week

4:48 pm ET January 3, 2022 (MarketWatch)

By Vivien Lou Chen and Barbara Kollmeyer

S&P 500, Dow, Nasdaq all post their biggest gains since Dec. 27

The Dow Jones Industrial Average and S&P 500 Index swept to record closes on Monday, driven by optimistic investors during the first day of trading in 2022, while joining the Nasdaq Composite in posting the biggest gains in a week. Among stocks on the move, shares of Tesla surged after record-breaking quarterly sales.

How did stock indexes trade?

For last year, the S&P 500 soared 26.9%, beating both the Nasdaq's 21.4% rise and the Dow's 18.7% climb.

Read: The S&P 500 beat both Dow, and Nasdaq in 2021 by the widest margin in 24 years. Here's what history says happens in 2022

What drove the stock market?

Stocks finished higher after a bumpy start to the session amid a number of lingering concerns -- including the surge in COVID-19 cases spurred by the rapid spread of the omicron coronavirus variant and the likelihood of multiple interest-rate hikes by the Federal Reserve, expected later this year.Read: Odds of a March rate hike by the Federal Reserve are back above 50%Financial markets were reflecting "broad optimism that the economy can weather omicron, as well as rate hikes from the Fed," said Tom Garretson, senior portfolio strategist at RBC Wealth Management, citing the resteepening of the Treasury yield curve to levels last seen around November. "The economic outlook should be strong enough to support all those things," he said via phone. The Nasdaq Composite Index led the way Monday among stock benchmarks as "most investors take a more optimistic view on large-cap tech companies being potentially able to adapt to pandemic conditions," said Timothy Chubb, chief investment officer at Girard, a wealth advisory firm in King of Prussia, Pennsylvania.Even as Treasury rates rose across the board, the historically negative correlation between higher yields and the Nasdaq index "hasn't necessarily held today," Chubb said via phone.

Travel chaos greeted the start of the year, with more than 2,600 U.S. flights canceled on Sunday, amid winter storms and shortages of workers due to the fast-spreading omicron variant. Federal offices were also shut in Washington, D.C, as winter weather bore down on the mid-Atlantic.

The final reading of the IHS Markit purchasing managers index for manufacturing edged down to 57.7 from an initial reading of 57.8.

Separately, spending on construction projects rose 0.4% in November at a seasonally adjusted annual rate of $1.63 trillion, the Commerce Department reported Monday. Economists polled by The Wall Street Journal had expected a 0.7% increase. Spending in October was raised to a 0.4% gain from the prior estimate of a 0.2% rise.

Which companies were in focus?

How did other assets trade?

Mark DeCambre and Mike Murphy contributed to this article

-Vivien Lou Chen


(END) Dow Jones Newswires

January 03, 2022 16:48 ET (21:48 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.